Hospital Txagorritxu

Vitoria-Gasteiz, Alava 01009

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Idiopathic Pulmonary Fibrosis

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With COVID-19 — Completed